Emergent BioSolutions to Lay Off About 400 Employees

Emergent BioSolutions on Tuesday decided to cut 400 jobs, pivoting its focus on core products such as overdose reversal nasal spray Narcan and anthrax vaccines.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/995257?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?